Which has better valuation & earnings, VSEC or EXPO?

Exponent has lower revenue, but higher earnings than VSE. Exponent is trading at a lower price-to-earnings ratio than VSE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSE $1.11B 4.56 $11.70M $2.37 76.19 Exponent $582.01M 4.97 $106.01M $2.15 27.75

Is VSEC or EXPO more profitable?

Exponent has a net margin of 18.07% compared to VSE's net margin of 4.95%. Exponent's return on equity of 27.94% beat VSE's return on equity. Company Net Margins Return on Equity Return on Assets VSE 4.95% 6.56% 4.68% Exponent 18.07% 27.94% 14.59%

Does the media refer more to VSEC or EXPO?

In the previous week, Exponent had 5 more articles in the media than VSE. MarketBeat recorded 6 mentions for Exponent and 1 mentions for VSE. VSE's average media sentiment score of 1.05 beat Exponent's score of 0.73 indicating that VSE is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VSE 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, EXPO or FCN?

FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 4.97 $106.01M $2.15 27.75 FTI Consulting $3.79B 1.27 $270.87M $8.41 19.00

Is EXPO or FCN more profitable?

Exponent has a net margin of 18.07% compared to FTI Consulting's net margin of 6.88%. Exponent's return on equity of 27.94% beat FTI Consulting's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 18.07% 27.94% 14.59% FTI Consulting 6.88% 15.14% 7.63%

Does the media favor EXPO or FCN?

In the previous week, FTI Consulting had 7 more articles in the media than Exponent. MarketBeat recorded 13 mentions for FTI Consulting and 6 mentions for Exponent. FTI Consulting's average media sentiment score of 1.28 beat Exponent's score of 0.73 indicating that FTI Consulting is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FTI Consulting 8 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, IHS or EXPO?

IHS has higher revenue and earnings than Exponent. IHS is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IHS $1.58B 1.76 $143.60M $0.53 15.67 Exponent $582.01M 4.97 $106.01M $2.15 27.75

Is IHS or EXPO more profitable?

Exponent has a net margin of 18.07% compared to IHS's net margin of 10.74%. Exponent's return on equity of 27.94% beat IHS's return on equity. Company Net Margins Return on Equity Return on Assets IHS 10.74% -1,351.44% 12.81% Exponent 18.07% 27.94% 14.59%

Does the media refer more to IHS or EXPO?

In the previous week, Exponent had 3 more articles in the media than IHS. MarketBeat recorded 6 mentions for Exponent and 3 mentions for IHS. Exponent's average media sentiment score of 0.73 beat IHS's score of 0.12 indicating that Exponent is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IHS 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Exponent 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, EXPO or CBZ?

CBIZ has higher revenue and earnings than Exponent. CBIZ is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 4.97 $106.01M $2.15 27.75 CBIZ $2.76B 0.66 $115.44M $2.49 13.62

Is EXPO or CBZ more profitable?

Exponent has a net margin of 18.07% compared to CBIZ's net margin of 5.57%. Exponent's return on equity of 27.94% beat CBIZ's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 18.07% 27.94% 14.59% CBIZ 5.57% 12.62% 5.17%

Does the media favor EXPO or CBZ?

In the previous week, Exponent had 2 more articles in the media than CBIZ. MarketBeat recorded 6 mentions for Exponent and 4 mentions for CBIZ. Exponent's average media sentiment score of 0.73 beat CBIZ's score of -0.01 indicating that Exponent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CBIZ 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HURN or EXPO?

In the previous week, Exponent had 2 more articles in the media than Huron Consulting Group. MarketBeat recorded 6 mentions for Exponent and 4 mentions for Huron Consulting Group. Huron Consulting Group's average media sentiment score of 0.87 beat Exponent's score of 0.73 indicating that Huron Consulting Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Huron Consulting Group 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Exponent (EXPO) Competitors

$59.66 +0.18 (+0.30%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$59.64 -0.02 (-0.03%)

As of 06/5/2026 05:59 PM Eastern

Compare

EXPO vs. VSEC, FCN, IHS, CBZ, and HURN

Should you buy Exponent stock or one of its competitors? MarketBeat compares Exponent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Exponent include VSE (VSEC), FTI Consulting (FCN), IHS (IHS), CBIZ (CBZ), and Huron Consulting Group (HURN). These companies are all part of the "research & consulting services" industry.

How does Exponent compare to VSE?

VSE (NASDAQ:VSEC) and Exponent (NASDAQ:EXPO) are both mid-cap research & consulting services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

91.5% of VSE shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 1.8% of VSE shares are owned by company insiders. Comparatively, 1.6% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

VSE has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, Exponent has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market.

Exponent has a net margin of 18.07% compared to VSE's net margin of 4.95%. Exponent's return on equity of 27.94% beat VSE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSE	4.95%	6.56%	4.68%
Exponent	18.07%	27.94%	14.59%

In the previous week, Exponent had 5 more articles in the media than VSE. MarketBeat recorded 6 mentions for Exponent and 1 mentions for VSE. VSE's average media sentiment score of 1.05 beat Exponent's score of 0.73 indicating that VSE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VSE	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Exponent	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

VSE pays an annual dividend of $0.40 per share and has a dividend yield of 0.2%. Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 2.1%. VSE pays out 16.9% of its earnings in the form of a dividend. Exponent pays out 57.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has increased its dividend for 12 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

VSE currently has a consensus target price of $239.13, suggesting a potential upside of 32.44%. Exponent has a consensus target price of $77.50, suggesting a potential upside of 29.90%. Given VSE's stronger consensus rating and higher probable upside, analysts plainly believe VSE is more favorable than Exponent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSE	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.91
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Exponent has lower revenue, but higher earnings than VSE. Exponent is trading at a lower price-to-earnings ratio than VSE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSE	$1.11B	4.56	$11.70M	$2.37	76.19
Exponent	$582.01M	4.97	$106.01M	$2.15	27.75

Summary

VSE beats Exponent on 11 of the 20 factors compared between the two stocks.

How does Exponent compare to FTI Consulting?

Exponent (NASDAQ:EXPO) and FTI Consulting (NYSE:FCN) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Exponent has a net margin of 18.07% compared to FTI Consulting's net margin of 6.88%. Exponent's return on equity of 27.94% beat FTI Consulting's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
FTI Consulting	6.88%	15.14%	7.63%

Exponent presently has a consensus target price of $77.50, indicating a potential upside of 29.90%. FTI Consulting has a consensus target price of $174.50, indicating a potential upside of 9.23%. Given Exponent's stronger consensus rating and higher possible upside, equities research analysts plainly believe Exponent is more favorable than FTI Consulting.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
FTI Consulting	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	4.97	$106.01M	$2.15	27.75
FTI Consulting	$3.79B	1.27	$270.87M	$8.41	19.00

92.4% of Exponent shares are owned by institutional investors. Comparatively, 99.4% of FTI Consulting shares are owned by institutional investors. 1.6% of Exponent shares are owned by company insiders. Comparatively, 1.8% of FTI Consulting shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Exponent has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, FTI Consulting has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market.

In the previous week, FTI Consulting had 7 more articles in the media than Exponent. MarketBeat recorded 13 mentions for FTI Consulting and 6 mentions for Exponent. FTI Consulting's average media sentiment score of 1.28 beat Exponent's score of 0.73 indicating that FTI Consulting is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
FTI Consulting	8 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Exponent beats FTI Consulting on 9 of the 16 factors compared between the two stocks.

How does Exponent compare to IHS?

IHS (NYSE:IHS) and Exponent (NASDAQ:EXPO) are both mid-cap research & consulting services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

In the previous week, Exponent had 3 more articles in the media than IHS. MarketBeat recorded 6 mentions for Exponent and 3 mentions for IHS. Exponent's average media sentiment score of 0.73 beat IHS's score of 0.12 indicating that Exponent is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IHS	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Exponent	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

17.5% of IHS shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 1.6% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IHS presently has a consensus price target of $8.38, suggesting a potential upside of 0.84%. Exponent has a consensus price target of $77.50, suggesting a potential upside of 29.90%. Given Exponent's stronger consensus rating and higher probable upside, analysts clearly believe Exponent is more favorable than IHS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IHS	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

IHS has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Exponent has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market.

Exponent has a net margin of 18.07% compared to IHS's net margin of 10.74%. Exponent's return on equity of 27.94% beat IHS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IHS	10.74%	-1,351.44%	12.81%
Exponent	18.07%	27.94%	14.59%

IHS has higher revenue and earnings than Exponent. IHS is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IHS	$1.58B	1.76	$143.60M	$0.53	15.67
Exponent	$582.01M	4.97	$106.01M	$2.15	27.75

Summary

Exponent beats IHS on 12 of the 15 factors compared between the two stocks.

How does Exponent compare to CBIZ?

Exponent (NASDAQ:EXPO) and CBIZ (NYSE:CBZ) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

92.4% of Exponent shares are owned by institutional investors. Comparatively, 87.4% of CBIZ shares are owned by institutional investors. 1.6% of Exponent shares are owned by company insiders. Comparatively, 4.1% of CBIZ shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CBIZ has higher revenue and earnings than Exponent. CBIZ is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	4.97	$106.01M	$2.15	27.75
CBIZ	$2.76B	0.66	$115.44M	$2.49	13.62

In the previous week, Exponent had 2 more articles in the media than CBIZ. MarketBeat recorded 6 mentions for Exponent and 4 mentions for CBIZ. Exponent's average media sentiment score of 0.73 beat CBIZ's score of -0.01 indicating that Exponent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CBIZ	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Exponent has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, CBIZ has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Exponent has a net margin of 18.07% compared to CBIZ's net margin of 5.57%. Exponent's return on equity of 27.94% beat CBIZ's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
CBIZ	5.57%	12.62%	5.17%

Exponent presently has a consensus target price of $77.50, indicating a potential upside of 29.90%. CBIZ has a consensus target price of $37.33, indicating a potential upside of 10.08%. Given Exponent's stronger consensus rating and higher probable upside, research analysts plainly believe Exponent is more favorable than CBIZ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
CBIZ	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.43

Summary

Exponent beats CBIZ on 10 of the 16 factors compared between the two stocks.

How does Exponent compare to Huron Consulting Group?

Huron Consulting Group (NASDAQ:HURN) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

In the previous week, Exponent had 2 more articles in the media than Huron Consulting Group. MarketBeat recorded 6 mentions for Exponent and 4 mentions for Huron Consulting Group. Huron Consulting Group's average media sentiment score of 0.87 beat Exponent's score of 0.73 indicating that Huron Consulting Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Huron Consulting Group	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Exponent	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Huron Consulting Group has a beta of 0.09, indicating that its share price is 91% less volatile than the broader market. Comparatively, Exponent has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market.

93.9% of Huron Consulting Group shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 2.1% of Huron Consulting Group shares are owned by company insiders. Comparatively, 1.6% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Huron Consulting Group presently has a consensus price target of $205.50, suggesting a potential upside of 86.82%. Exponent has a consensus price target of $77.50, suggesting a potential upside of 29.90%. Given Huron Consulting Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Huron Consulting Group is more favorable than Exponent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huron Consulting Group	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Exponent has a net margin of 18.07% compared to Huron Consulting Group's net margin of 5.94%. Huron Consulting Group's return on equity of 29.41% beat Exponent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huron Consulting Group	5.94%	29.41%	9.10%
Exponent	18.07%	27.94%	14.59%

Exponent has lower revenue, but higher earnings than Huron Consulting Group. Huron Consulting Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huron Consulting Group	$1.70B	1.05	$105.04M	$5.86	18.77
Exponent	$582.01M	4.97	$106.01M	$2.15	27.75

Summary

Huron Consulting Group beats Exponent on 9 of the 16 factors compared between the two stocks.

Get Exponent News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXPO vs. The Competition

Export

Metric	Exponent	Consulting Industry	Business Sector	NASDAQ Exchange
Market Cap	$2.89B	$4.27B	$6.65B	$11.99B
Dividend Yield	2.08%	2.50%	3.05%	5.56%
P/E Ratio	27.75	14.86	28.00	23.62
Price / Sales	4.97	2.03	393.54	110.64
Price / Cash	25.64	12.11	22.86	37.22
Price / Book	7.63	5.92	5.80	6.66
Net Income	$106.01M	$245.85M	$207.08M	$337.55M
7 Day Performance	2.30%	0.38%	-0.79%	-2.52%
1 Month Performance	-5.96%	-4.48%	0.05%	-0.03%
1 Year Performance	-22.93%	-24.50%	31.81%	25.34%

Exponent Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXPO Exponent	4.6531 of 5 stars	$59.66 +0.3%	$77.50 +29.9%	-22.9%	$2.89B	$582.01M	27.75	1,212	News Coverage Positive News Analyst Forecast
VSEC VSE	4.1776 of 5 stars	$180.32 -2.6%	$239.13 +32.6%	+35.1%	$5.19B	$1.11B	76.08	1,600
FCN FTI Consulting	4.1361 of 5 stars	$155.06 +1.2%	$174.50 +12.5%	-2.6%	$4.62B	$3.79B	18.44	8,118	News Coverage Positive News Buyback Announcement Gap Up
IHS IHS	1.2827 of 5 stars	$8.34 +0.4%	$8.38 +0.5%	+47.1%	$2.78B	$1.58B	15.73	2,762
CBZ CBIZ	4.3481 of 5 stars	$34.61 +4.3%	$37.33 +7.9%	-54.2%	$1.78B	$2.76B	13.90	9,500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EXPO) was last updated on 6/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Competitors